More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Cimetra import approval granted for india

Sep 3, 2021 at 12:03 AM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Sep 3, 2021 at 12:03 AM EDT

On 6ix: 6ix.com/news/cimetra-import-approval-granted-for-india

Argent Biopharma Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Story so far

  • Cimetra patent submitted to european ip officeMay 18, 2021
  • Ethics Committee Approval Granted Phase III Clinical TrialMar 23, 2021
  • MXC Cannabis Research Permit Granted for RMIT ProgramsJul 14, 2020

Earlier from Argent Biopharma

  • Mgc pharma executes US$24M US supply agreementAug 26, 2021
  • Patent application lodged for novel drug delivery systemJul 15, 2021
  • 1St patient recruited into cimetra phase 3 clinical trialJul 12, 2021
  • Cannepil available for free dispensing in irelandJun 14, 2021
  • Mgc pharma 2021 clinical trials program updateMay 24, 2021

Later from Argent Biopharma

  • Uk import permit granted for cannepilSep 13, 2021
  • Artemic eu sale approval and clinical trial updateSep 15, 2021
  • First order received under US supply agreementSep 29, 2021
  • Amc inc. places US$3M cimetra purchase orderOct 6, 2021
  • Response to ASX Query LetterOct 15, 2021
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer